| Ranked All-Publication list | Historiographs | Glossary HistCite Guide About |
| Nodes: 2913, Authors: 7350, Journals: 871, Outer References: 80285, Words: 5113
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by LCR. |
Page 1 of 30: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 32 | 128 | 2824 2005 MICROBES AND INFECTION 7 (5-6): 911-921 Andersen P; Doherty TM TB subunit vaccines - putting the pieces together | 0 | 1 |
| 2 | 30 | 92 | 2830 2005 NATURE REVIEWS MICROBIOLOGY 3 (8): 656-662 Andersen P; Doherty TM The success and failure of BCG - implications for a novel tuberculosis vaccine | 3 | 8 |
| 3 | 29 | 195 | 2761 2005 CLINICAL MICROBIOLOGY REVIEWS 18 (4): 687-+ Doherty TM; Andersen P Vaccines for tuberculosis: Novel concepts and recent progress | 0 | 2 |
| 4 | 24 | 145 | 473 1986 JOURNAL OF MEDICAL TECHNOLOGY 3 (10): 511-521 BARR JT IMPROVED LABORATORY UTILIZATION AND INFORMATION PRODUCTION - THE ADMINISTRATORS NEW ROLE | 1 | 2 |
| 5 | 24 | 75 | 2519 2003 IMMUNOLOGY AND CELL BIOLOGY 81 (1): 34-45 Britton WJ; Palendira U Improving vaccines against tuberculosis | 6 | 17 |
| 6 | 22 | 79 | 2402 2002 EXPERT OPINION ON BIOLOGICAL THERAPY 2 (7): 741-749 Sacksteder KA; Nary CA New tuberculosis vaccine development | 1 | 3 |
| 7 | 22 | 83 | 2780 2005 HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN II 568: 117-134 Teo SSS; Shingadia D BCG vaccine | 0 | 0 |
| 8 | 21 | 91 | 2214 2000 PHARMACOECONOMICS 17 (2): 151-165 Green C; Brazier J; Deverill M Valuing health-related quality of life - A review of health state valuation techniques | 4 | 35 |
| 9 | 21 | 66 | 2860 2005 VACCINE 23 (17-18): 2109-2114 Doherty TM Real world TB vaccines: clinical trials in TB-endemic regions | 0 | 1 |
| 10 | 20 | 66 | 2390 2002 CLINICAL INFECTIOUS DISEASES 35 (4): 465-474 von Reyn CF; Vuola JM New vaccines for the prevention of tuberculosis | 3 | 13 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 11 | 20 | 79 | 2477 2002 VACCINE 21 (1-2): 7-14 Agger EM; Andersen P A novel TB vaccine; towards a strategy based on our understanding of BCG failure | 5 | 12 |
| 12 | 19 | 53 | 2766 2005 CURRENT OPINION IN INFECTIOUS DISEASES 18 (3): 211-215 Haile M; Kallenius G Recent developments in tuberculosis vaccines | 0 | 1 |
| 13 | 19 | 56 | 2912 2006 VETERINARY MICROBIOLOGY 112 (2-4): 163-169 Dietrich J; Weldingh K; Andersen P Prospects for a novel vaccine against tuberculosis | 0 | 0 |
| 14 | 18 | 354 | 431 1985 WHO TECHNICAL REPORT SERIES (723): 7-67 [Anon] THE FUTURE USE OF NEW IMAGING TECHNOLOGIES IN DEVELOPING-COUNTRIES | 0 | 0 |
| 15 | 18 | 145 | 2100 2000 ANNUAL REVIEW OF PUBLIC HEALTH 21: 587-611 Neumann PJ; Goldie SJ; Weinstein MC Preference-based measures in economic evaluation in health care | 5 | 28 |
| 16 | 18 | 111 | 2279 2001 EMERGENCY MEDICINE CLINICS OF NORTH AMERICA 19 (1): 35-+ Wilkinson K; Severance H Identification of chest pain patients appropriate for an emergency department observation unit | 0 | 2 |
| 17 | 18 | 96 | 2489 2003 ANNALS OF INTERNAL MEDICINE 139 (12): 987-995 Goldman L; Kirtane AJ Triage of patients with acute chest pain and possible cardiac ischemia: The elusive search for diagnostic perfection | 0 | 9 |
| 18 | 17 | 173 | 2195 2000 MEDICAL CARE 38 (6): 583-637 Tengs TO; Wallace A One thousand health-related quality-of-life estimates | 5 | 90 |
| 19 | 17 | 67 | 2520 2003 IMMUNOLOGY LETTERS 85 (2): 207-211 Olsen AW; Andersen P A novel TB vaccine; strategies to combat a complex pathogen | 5 | 9 |
| 20 | 17 | 82 | 2720 2004 TUBERCULOSIS 84 (1-2): 102-109 Nor NM; Musa M Approaches towards the development of a vaccine against tuberculosis: recombinant BCG and DNA vaccine | 2 | 4 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 21 | 17 | 81 | 2778 2005 HEALTH ECONOMICS 14 (1): 39-53 Arnesen T; Trommald M Are QALYs based on time trade-off comparable? - A systematic review of TTO methodologies | 0 | 0 |
| 22 | 16 | 58 | 710 1989 BRITISH JOURNAL OF SURGERY 76 (3): 230-236 BARDHAN KD; CUST G; HINCHLIFFE RFC; WILLIAMSON FM; LYON C; et al. CHANGING PATTERN OF ADMISSIONS AND OPERATIONS FOR DUODENAL-ULCER | 3 | 46 |
| 23 | 16 | 124 | 2637 2004 HEALTH TECHNOLOGY ASSESSMENT 8 (17): 1-+ Gilbert FJ; Grant AM; Gillan MGC; Vale L; Scott NW; et al. Does early magnetic resonance imaging influence management or improve outcome in patients referred to secondary care with low back pain? A pragmatic randomised controlled trial | 0 | 2 |
| 24 | 16 | 38 | 2885 2006 INFECTION AND IMMUNITY 74 (3): 1718-1724 Castillo-Rodal AI; Castanon-Arreola M; Hernandez-Pando R; Calva JJ; Sada-Diaz E; et al. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis | 0 | 0 |
| 25 | 16 | 80 | 2886 2006 INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 10 (2): 93-102 Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates | 0 | 0 |
| 26 | 15 | 69 | 2719 2004 TROPICAL MEDICINE & INTERNATIONAL HEALTH 9 (7): 818-826 Doherty TM New vaccines against tuberculosis | 1 | 8 |
| 27 | 15 | 117 | 2839 2005 RADIOLOGY 235 (2): 361-370 Gazelle GS; McMahon PM; Siebert U; Beinfeld MT Cost-effectiveness analysis in the assessment of diagnostic Imaging technologies | 0 | 2 |
| 28 | 14 | 132 | 1664 1997 INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 13 (4): 613-630 Sassi F; McKee M; Roberts JA Economic evaluation of diagnostic technology - Methodological challenges and viable solutions | 3 | 7 |
| 29 | 14 | 62 | 2029 1999 MEDICAL DECISION MAKING 19 (4): 487-498 Nickerson CAE Assessing convergent validity of health-state utilities obtained using different scaling methods | 1 | 3 |
| 30 | 14 | 180 | 2775 2005 EXPERT OPINION ON PHARMACOTHERAPY 6 (6): 891-913 Cavassini ML; D'Acremont V; Furrer H; Genton B; Tarr PE Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 31 | 14 | 113 | 2911 2006 VETERINARY JOURNAL 171 (2): 229-244 Vordermeier HM; Chambers MA; Buddle BM; Pollock JM; Hewinson RG Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle | 0 | 0 |
| 32 | 13 | 51 | 1381 1995 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 26 (4): 914-919 TSEVAT J; DUKE D; GOLDMAN L; PFEFFER MA; LAMAS GA; et al. COST-EFFECTIVENESS OF CAPTOPRIL THERAPY AFTER MYOCARDIAL-INFARCTION | 4 | 77 |
| 33 | 13 | 60 | 1465 1996 CHEST 109 (5): 1359-1369 Willens HJ; Chakko S; Simmons J; Kessler KM Cost-effectiveness in clinical cardiology .1. Coronary artery disease and congestive heart failure | 1 | 5 |
| 34 | 13 | 34 | 1468 1996 CIRCULATION 94 (2): 143-150 Tosteson ANA; Goldman L; Udvarhelyi IS; Lee TH Cost-effectiveness of a coronary care unit versus an intermediate care unit for emergency department patients with chest pain | 8 | 23 |
| 35 | 13 | 307 | 1617 1997 ANNALS OF EMERGENCY MEDICINE 29 (1): 13-87 Selker HP; Zalenski RJ; Antman EM; Aufderheide TP; Bernard SA; et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: A report from a National Heart Attack Alert Program Working Group | 6 | 81 |
| 36 | 13 | 94 | 1731 1997 WIENER KLINISCHE WOCHENSCHRIFT 109: 6-16 Oldridge NB Cardiac rehabilitation and risk factor management after myocardial infarction - Clinical and economic evaluation | 0 | 1 |
| 37 | 13 | 67 | 1783 1998 EMERGENCY MEDICINE CLINICS OF NORTH AMERICA 16 (3): 495-+ Zalenski RJ; Shamsa F; Pede KJ Evaluation and risk stratification of patients with chest pain in the emergency department - Predictors of life-threatening events | 2 | 11 |
| 38 | 13 | 135 | 1823 1998 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 280 (6): 550-558 van Walraven C; Naylor CD Do we know what inappropriate laboratory utilization is? - A systematic review of laboratory clinical audits | 2 | 59 |
| 39 | 13 | 50 | 2045 1999 PHARMACOECONOMICS 15 (2): 119-127 Dolan P Valuing health-related quality of life - Issues and controversies | 0 | 7 |
| 40 | 13 | 51 | 2327 2001 JOURNAL OF RHEUMATOLOGY 28 (3): 648-656 Suarez-Almazor ME; Conner-Spady B Rating of arthritis health states by patients, physicians, and the general public. Implications for cost-utility analyses | 1 | 11 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 41 | 13 | 190 | 2375 2002 AMERICAN JOURNAL OF PREVENTIVE MEDICINE 23 (4): 276-289 Neumann PJ; Levine BS Do HEDIS measures reflect cost-effective practices? | 0 | 7 |
| 42 | 13 | 85 | 2534 2003 INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 292 (7-8): 441-451 Dietrich G; Viret JF; Hess J Novel vaccination strategies based on recombinant Mycobacterium bovis BCG | 1 | 6 |
| 43 | 13 | 53 | 2590 2003 VACCINE 21 (17-18): 2152-2160 Barbosa T; Arruda S; Fernandes BD; Carvalho LP; Cardoso S; et al. BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children | 0 | 0 |
| 44 | 13 | 30 | 2724 2004 VACCINE 23 (6): 780-788 Derrick SC; Yang AL; Morris SL A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity | 3 | 8 |
| 45 | 12 | 141 | 1018 1992 EPIDEMIOLOGIC REVIEWS 14: 154-176 DICKERSIN K; BERLIN JA METAANALYSIS - STATE-OF-THE-SCIENCE | 9 | 224 |
| 46 | 12 | 32 | 1259 1994 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 24 (5): 1249-1259 GASPOZ JM; LEE TH; WEINSTEIN MC; COOK EF; GOLDMAN P; et al. COST-EFFECTIVENESS OF A NEW SHORT-STAY UNIT TO RULE OUT ACUTE MYOCARDIAL-INFARCTION IN LOW-RISK PATIENTS | 17 | 95 |
| 47 | 12 | 60 | 1354 1995 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 16 (4): 240-247 FERGUSON BM; KEOWN PA AN INTRODUCTION TO UTILITY MEASUREMENT IN HEALTH-CARE | 0 | 15 |
| 48 | 12 | 227 | 1413 1995 PROGRESS IN CARDIOVASCULAR DISEASES 37 (5): 307-346 KUPERSMITH J; HOLMESROVNER M; HOGAN A; ROVNER D; GARDINER J COST-EFFECTIVENESS ANALYSIS IN HEART-DISEASE .3. ISCHEMIA, CONGESTIVE-HEART-FAILURE, AND ARRHYTHMIAS | 3 | 43 |
| 49 | 12 | 66 | 1767 1998 CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES 49 (5): 295-306 Stolberg HO; Norman GR; Moran LA; Gafni A A core curriculum in the evaluative sciences for diagnostic imaging | 0 | 5 |
| 50 | 12 | 225 | 2267 2001 CLINICAL INFECTIOUS DISEASES 32 (3): 331-351 Guerrant RL; Van Gilder T; Steiner TS; Thielman NM; Slutsker L; et al. Practice guidelines for the management of infectious diarrhea | 1 | 88 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 51 | 12 | 30 | 2351 2001 RADIOLOGY 220 (2): 393-399 Gillan MGC; Gilbert FJ; Andrew JE; Grant AM; Wardlaw D; et al. Influence of imaging on clinical decision making in the treatment of lower back pain | 1 | 9 |
| 52 | 12 | 25 | 2352 2001 RADIOLOGY 220 (3): 589-593 Hobby JL; Dixon AK; Bearcroft PWP; Tom BDM; Lomas DJ; et al. MR imaging of the wrist: Effect on clinical diagnosis and patient care | 0 | 6 |
| 53 | 12 | 249 | 2638 2004 HEALTH TECHNOLOGY ASSESSMENT 8 (25): 1-+ Whiting P; Rutjes AWS; Dinnes J; Reitsma JB; Bossuyt PMM; et al. Development and validation of methods for assessing the quality of diagnostic accuracy studies | 0 | 2 |
| 54 | 12 | 309 | 2764 2005 CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS 22 (2): 151-214 Bramwell VW; Perrie Y Particulate delivery systems for vaccines | 0 | 3 |
| 55 | 12 | 51 | 2769 2005 DRUGS 65 (17): 2437-2444 Orme IM Tuberculosis vaccines - Current progress | 0 | 0 |
| 56 | 11 | 100 | 835 1990 GASTROENTEROLOGY CLINICS OF NORTH AMERICA 19 (2): 255-271 GILINSKY NH PEPTIC-ULCER DISEASE IN THE ELDERLY | 0 | 17 |
| 57 | 11 | 121 | 1108 1993 BAILLIERES CLINICAL GASTROENTEROLOGY 7 (1): 129-148 MCCLOY R; NAIR R SURGERY FOR ACID SUPPRESSION IN THE 1990S | 0 | 3 |
| 58 | 11 | 60 | 1331 1995 CLINICAL RADIOLOGY 50 (8): 513-518 MACKENZIE R; DIXON AK MEASURING THE EFFECTS OF IMAGING - AN EVALUATIVE FRAMEWORK | 20 | 52 |
| 59 | 11 | 108 | 1450 1996 ANNUAL REVIEW OF PUBLIC HEALTH 17: 467-488 Holtgrave DR; Qualls NL; Graham JD Economic evaluation of HIV prevention programs | 5 | 43 |
| 60 | 11 | 29 | 2025 1999 MEDICAL CARE 37 (6): 580-588 Giesler RB; Ashton CM; Brody B; Byrne MM; Cook K; et al. Assessing the performance of utility techniques in the absence of a gold standard | 7 | 26 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 61 | 11 | 50 | 2049 1999 QUALITY OF LIFE RESEARCH 8 (5): 399-409 Lalonde L; Clarke AE; Joseph L; Mackenzie T; Grover SA Comparing the psychometric properties of preference-based and nonpreference-based health-related quality of life in coronary heart disease | 1 | 18 |
| 62 | 11 | 424 | 2087 2000 ADVANCES IN IMMUNOLOGY, VOL 75 75: 1-88 Hess J; Schaible U; Raupach B; Kaufmann SHE Exploiting the immune system: Toward new vaccines against intracellular bacteria | 4 | 35 |
| 63 | 11 | 73 | 2142 2000 HEALTH ECONOMICS 9 (2): 109-126 De Wit GA; Busschbach JJV; De Charro FT Sensitivity and perspective in the valuation of health status: Whose values count? | 2 | 29 |
| 64 | 11 | 48 | 2382 2002 BRITISH MEDICAL BULLETIN 62: 73-86 Young DB; Stewart GR Tuberculosis vaccines | 5 | 12 |
| 65 | 11 | 56 | 2536 2003 INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 19 (1): 135-147 Ross PL; Littenberg B; Fearn P; Scardino PT; Karakiewicz PI; et al. Paper standard gamble - A paper-based measure of standard gamble utility for current health | 1 | 5 |
| 66 | 11 | 39 | 2628 2004 EMERGING INFECTIOUS DISEASES 10 (9): 1529-1535 Ziv E; Daley CL; Blower S Potential public health impact of new tuberculosis vaccines | 2 | 3 |
| 67 | 11 | 43 | 2635 2004 HEALTH ECONOMICS 13 (3): 281-290 Salomon JA; Murray CJL A multi-method approach to measuring health-state valuations | 0 | 7 |
| 68 | 11 | 42 | 2643 2004 INFECTION AND IMMUNITY 72 (1): 381-388 Vekemans J; Ota MOC; Sillah J; Fielding K; Alderson MR; et al. Immune responses to mycobacterial antigens in the Gambian population: Implications for vaccines and immunodiagnostic test design | 0 | 6 |
| 69 | 11 | 39 | 2811 2005 JOURNAL OF IMMUNOLOGY 174 (10): 6332-6339 Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: Efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy | 2 | 4 |
| 70 | 11 | 24 | 2854 2005 TUBERCULOSIS 85 (1-2): 107-114 Haile M; Hamasur B; Jaxmar T; Gavier-Widen D; Chambers MA; et al. Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice | 1 | 4 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 71 | 10 | 82 | 819 1990 ARCHIVES OF INTERNAL MEDICINE 150 (12): 2451-2458 WOOLF SH; KAMEROW DB TESTING FOR UNCOMMON CONDITIONS - THE HEROIC SEARCH FOR POSITIVE TEST-RESULTS | 2 | 49 |
| 72 | 10 | 126 | 1281 1994 PROGRESS IN CARDIOVASCULAR DISEASES 37 (3): 161-184 KUPERSMITH J; HOLMESROVNER M; HOGAN A; ROVNER D; GARDINER J COST-EFFECTIVENESS ANALYSIS IN HEART-DISEASE .1. GENERAL-PRINCIPLES | 7 | 35 |
| 73 | 10 | 67 | 1357 1995 INTENSIVE CARE MEDICINE 21 (11): 952-961 CHALFIN DB; COHEN IL; LAMBRINOS J THE ECONOMICS AND COST-EFFECTIVENESS OF CRITICAL CARE MEDICINE | 2 | 56 |
| 74 | 10 | 48 | 1387 1995 MEDICAL CARE 33 (9): 922-937 RUTTENVANMOLKEN MPMH; BAKKER CH; VANDOORSLAER EKA; VANDERLINDEN S METHODOLOGICAL ISSUES OF PATIENT UTILITY MEASUREMENT - EXPERIENCE FROM 2 CLINICAL-TRIALS | 15 | 58 |
| 75 | 10 | 22 | 1411 1995 PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS 107 (3): 329-333 Goldman L Using prediction models and cost-effectiveness analysis to improve clinical decisions: Emergency department patients with acute chest pain | 0 | 3 |
| 76 | 10 | 85 | 1424 1995 STATISTICS IN MEDICINE 14 (2): 137-149 JONES DR METAANALYSIS - WEIGHING THE EVIDENCE | 0 | 27 |
| 77 | 10 | 40 | 1539 1996 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 28 (1): 25-33 Gomez MA; Anderson JL; Karagounis LA; Muhlestein JB; Mooers FB An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: Results of a randomized study (ROMIO) | 9 | 125 |
| 78 | 10 | 41 | 1560 1996 NEW ENGLAND JOURNAL OF MEDICINE 334 (23): 1498-1504 Goldman L; Cook EF; Johnson PA; Brand DA; Rouan GW; et al. Prediction of the need for intensive care in patients who come to emergency departments with acute chest pain | 17 | 125 |
| 79 | 10 | 27 | 1786 1998 EUROPEAN RADIOLOGY 8 (3): 488-490 Dixon AK The impact of medical imaging on the physician's diagnostic and therapeutic thinking | 2 | 8 |
| 80 | 10 | 32 | 2048 1999 QUALITY OF LIFE RESEARCH 8 (4): 303-310 Badia X; Monserrat S; Roset M; Herdman M Feasibility, validity and test-retest reliability of scaling methods for health states: The visual analogue scale and the time trade-off | 3 | 27 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 81 | 10 | 42 | 2184 2000 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 36 (6): 1803-1808 Calvin JE; Klein LW; VandenBerg EJ; Meyer P; Parrillo JE Validated risk stratification model accurately predicts low risk in patients with unstable angina | 1 | 13 |
| 82 | 10 | 21 | 2248 2001 AMERICAN JOURNAL OF MEDICINE 110 (1): 67-68 Goldman L Telemetry or not telemetry: A great leap forward or a waste of resources? | 0 | 1 |
| 83 | 10 | 45 | 2349 2001 QUALITY OF LIFE RESEARCH 10 (7): 621-635 Burstrom K; Johannesson M; Diderichsen F Swedish population health-related quality of life results using the EQ-5D | 1 | 34 |
| 84 | 10 | 45 | 2384 2002 BULLETIN OF THE WORLD HEALTH ORGANIZATION 80 (6): 483-488 Ginsberg AM What's new in tuberculosis vaccines? | 4 | 22 |
| 85 | 10 | 54 | 2501 2003 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 133 (2): 182-192 Lai X; Sh; en Y; Zhou D; Sehgal R; et al. Immune biology of macaque lymphocyte populations during mycobacterial infection | 1 | 5 |
| 86 | 10 | 34 | 2610 2004 ANNALS OF EMERGENCY MEDICINE 43 (1): 71-76 Hollander JE; Sites FD; Pollack CV; Shofer FS Lack of utility of telemetry monitoring for identification of cardiac death and life-threatening ventricular dysrhythmias in low-risk patients with chest pain | 0 | 8 |
| 87 | 10 | 39 | 2642 2004 INFECTION AND IMMUNITY 72 (1): 238-246 Chen LH; Wang J; Zganiacz A; Xing Z Single intranasal mucosal Mycobactetium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis | 1 | 10 |
| 88 | 10 | 61 | 2667 2004 JOURNAL OF IMMUNOLOGY 172 (12): 7618-7628 Skeiky YAW; Alderson MR; Ovendale PJ; Guderian JA; Brandt L; et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein | 15 | 38 |
| 89 | 10 | 35 | 2671 2004 JOURNAL OF INFECTIOUS DISEASES 190 (12): 2146-2153 Doherty TM; Olsen AW; Weischenfeldt J; Huygen K; D'Souza S; et al. Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis | 4 | 8 |
| 90 | 10 | 435 | 2736 2005 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 172 (9): 1169-1227 Nolan CM; Blumberg HM; Taylor Z; Bernardo J; Brennan PJ; et al. American thoracic society/centers for disease control and prevention/infectious diseases society of America: Controlling tuberculosis in the United States | 0 | 3 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 91 | 10 | 34 | 2790 2005 INFECTION AND IMMUNITY 73 (11): 7727-7735 Derrick SC; Yang AL; Morris SL Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis | 0 | 1 |
| 92 | 10 | 82 | 2805 2005 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 294 (20): 2623-2629 Swap CJ; Nagurney JT Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes | 0 | 6 |
| 93 | 10 | 41 | 2818 2005 JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE 11 (6): 508-515 Tuli K; Sansom S; Purcell DW; Metsch LR; Latkin CA; et al. Economic evaluation of an HIV prevention Intervention for Seropositive injection drug users | 0 | 0 |
| 94 | 10 | 91 | 2829 2005 NATURE REVIEWS IMMUNOLOGY 5 (8): 661-667 Rook GAW; Dheda K; Zumla A Immune responses to tuberculosis in developing countries: implications for new vaccines | 1 | 5 |
| 95 | 10 | 53 | 2857 2005 TUBERCULOSIS 85 (5-6): 377-383 Latchumanan VK; Balkhi MY; Sinha A; Singh B; Sharma P; et al. Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells | 0 | 0 |
| 96 | 10 | 74 | 2862 2005 VACCINE 23 (17-18): 2121-2131 De Groot AS; McMurry J; Marcon L; Franco J; Rivera D; et al. Developing an epitope-driven tuberculosis (TB) vaccine | 0 | 3 |
| 97 | 10 | 147 | 2871 2006 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 173 (10): 1078-1090 Marais BJ; Gie RP; Schaaf HS; Beyers N; Donald PR; et al. Childhood pulmonary tuberculosis - Old wisdom and new challenges | 0 | 0 |
| 98 | 10 | 29 | 2877 2006 CLINICAL INFECTIOUS DISEASES 42 (4): 559-561 von Reyn CF Routine childhood bacille Calmette Guerin immunization and HIV infection | 1 | 1 |
| 99 | 10 | 31 | 2881 2006 HEALTH POLICY 76 (3): 359-370 Burstrom K; Johannesson M; Diderichsen F A comparison of individual and social time trade-off values for health states in the general population | 0 | 0 |
| 100 | 10 | 24 | 2890 2006 JOURNAL OF INFECTIOUS DISEASES 193 (4): 531-536 Davids V; Hanekom WA; Mansoor N; Gamieldien H; Gelderbloem SJ; et al. The effect of bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants | 0 | 0 |
Page 1 of 30: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21
Generated by HistCite 2006.05.24